ici 164384 has been researched along with fulvestrant in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (83.33) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bélanger, A; Caron, B; Cloutier, J; Dory, YL; Favre, A; Gauthier, S; Labrie, C; Labrie, F; Larouche, D; Leblanc, G; Mailhot, J; Martel, C; Mérand, Y; Ouellet, C; Schwerdtfeger, A; Simard, J | 1 |
| Bowler, J; Wakeling, AE | 1 |
| Gee, JM; Katzenellenbogen, BS; Manning, DL; Montano, MM; Nicholson, RI; Wakeling, AE | 1 |
| Collins, DC; Gagliardi, A | 1 |
| Briand, P; Larsen, SS; Lykkesfeldt, AE | 1 |
| Buric, R; Newton, CJ; Pagotto, U; Renner, U; Stalla, GK; Trapp, T | 1 |
| Cavaillès, V; Danielian, PS; Dauvois, S; Parker, MG | 1 |
| Crew, AJ; Langdon, SP; Miller, WR; Muir, M; Ritchie, AA; Smyth, JF; Wakeling, A | 1 |
| Dauvois, S; Parker, MG; White, R | 1 |
| Briand, P; Lykkesfeldt, AE; Madsen, MW | 1 |
| Brockmeier, S; Buric, R; Newton, CJ; Pagotto, U; Stalla, GK; Trapp, T | 1 |
| Parker, MG | 1 |
| Brünner, N; Clarke, R; Coopman, P; Derocq, D; Garcia, M; Rochefort, H | 1 |
| Manning, DL; Nicholson, RI | 1 |
| Clerico, L; de Cupis, A; Favoni, RE; Ferrera, A; Noonan, D; Pirani, P | 1 |
| Briand, P; Larsen, SS; Lykkesfeldt, AE; Madsen, MW; Reiter, BE | 1 |
| Conover, CA; Harris, SA; Kassem, M; Okazaki, R; Riggs, BL; Spelsberg, TC | 1 |
| Musgrove, EA; Prall, OW; Sutherland, RL; Wilcken, NR | 1 |
| Kuiper, GG; Pols, HA; Van Den Bemd, GJ; Van Leeuwen, JP | 1 |
| Egeblad, M; Jäättelä, M; Larsen, SS; Lykkesfeldt, AE | 1 |
| Elkak, AE; Mokbel, K | 1 |
| Brockdorff, BL; Heiberg, I; Lykkesfeldt, AE | 1 |
| Espelund, U; Jepsen, JS; Juncker-Jensen, A; Lykkesfeldt, AE; Ralfkiaer, U; Worm, J | 1 |
| Fichtner, I; Frogne, T; Issinger, OG; Lykkesfeldt, AE; Stenvang, J; Yde, CW | 1 |
3 review(s) available for ici 164384 and fulvestrant
| Article | Year |
|---|---|
Development of novel oestrogen-receptor antagonists.
Topics: Animals; Breast Neoplasms; Drug Design; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Neoplasms, Hormone-Dependent; Polyunsaturated Alkamides; Receptors, Estrogen; Tamoxifen | 1991 |
Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer.
Topics: Breast Neoplasms; Drug Resistance; Estradiol; Estradiol Congeners; Estrogen Antagonists; Female; Fulvestrant; Humans; In Vitro Techniques; Polyunsaturated Alkamides; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1995 |
Pure antiestrogens and breast cancer.
Topics: Antineoplastic Agents, Hormonal; Benzopyrans; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Piperidines; Polyunsaturated Alkamides; Propionates | 2001 |
21 other study(ies) available for ici 164384 and fulvestrant
| Article | Year |
|---|---|
(S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen.
Topics: Administration, Oral; Animals; Benzopyrans; Binding, Competitive; Breast Neoplasms; Cytosol; Diethylstilbestrol; Estradiol; Estrogen Antagonists; Female; Humans; Mice; Molecular Structure; Ovariectomy; Piperidines; Propionates; Raloxifene Hydrochloride; Receptors, Estrogen; Stereoisomerism; Structure-Activity Relationship; Uterus | 1997 |
Inhibition of angiogenesis by antiestrogens.
Topics: Animals; Chick Embryo; Clomiphene; Dimethyl Sulfoxide; Dimethylformamide; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Estrogen Antagonists; Fulvestrant; Heparin; Hydrocortisone; Nafoxidine; Neovascularization, Pathologic; Polyunsaturated Alkamides; Solubility; Tamoxifen | 1993 |
Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Polyunsaturated Alkamides; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured | 1995 |
The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen.
Topics: Animals; Base Sequence; Cell Division; Culture Media, Serum-Free; Estradiol; Fulvestrant; Insulin; Insulin-Like Growth Factor I; Molecular Sequence Data; Neoplasm Proteins; Pituitary Neoplasms; Polyunsaturated Alkamides; Rats; Receptors, Estrogen; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; Transfection; Tumor Cells, Cultured; Vitellogenins | 1994 |
Interaction of proteins with transcriptionally active estrogen receptors.
Topics: Animals; Base Sequence; Blotting, Western; Cell Line; Cell Nucleus; Cell-Free System; Chlorocebus aethiops; DNA Primers; DNA-Binding Proteins; Estradiol; Estrogen Antagonists; Fulvestrant; Glutathione Transferase; HeLa Cells; Humans; Kidney; Molecular Sequence Data; Nuclear Proteins; Polyunsaturated Alkamides; Receptors, Estrogen; Recombinant Fusion Proteins; Tamoxifen; Transcription, Genetic | 1994 |
Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model.
Topics: Adenocarcinoma; Animals; Cell Division; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Polyunsaturated Alkamides; Receptors, Estrogen; Tamoxifen; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling.
Topics: Amino Acid Sequence; Animals; Biological Transport; Cell Compartmentation; Cell Nucleus; Cells, Cultured; Chlorocebus aethiops; Cytoplasm; Estradiol; Estrogen Antagonists; Fulvestrant; Hybrid Cells; Mice; Molecular Sequence Data; Oligomycins; Polyunsaturated Alkamides; Receptors, Estrogen; Recombinant Proteins; Sequence Homology, Amino Acid; Tamoxifen; Transfection | 1993 |
Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Topics: Animals; Base Sequence; Breast Neoplasms; Cell Division; Chloramphenicol O-Acetyltransferase; Culture Media; Drug Resistance; Drug Screening Assays, Antitumor; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Polyunsaturated Alkamides; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Time Factors; Transfection; Tumor Cells, Cultured | 1994 |
The unliganded estrogen receptor (ER) transduces growth factor signals.
Topics: Base Sequence; Cell Division; Culture Media, Conditioned; Culture Media, Serum-Free; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Insulin; Insulin-Like Growth Factor I; Ligands; Molecular Sequence Data; Oligodeoxyribonucleotides; Pituitary Neoplasms; Polyunsaturated Alkamides; Receptors, Estrogen; Signal Transduction; Tumor Cells, Cultured | 1994 |
Action of "pure" antiestrogens in inhibiting estrogen receptor action.
Topics: Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Polyunsaturated Alkamides; Receptors, Estrogen | 1993 |
Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cathepsin D; Cell Division; Drug Resistance; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Polyunsaturated Alkamides; Proteins; Receptors, Estrogen; Tamoxifen; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1994 |
Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestins.
Topics: Breast Neoplasms; DNA, Neoplasm; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Tumor Cells, Cultured | 1993 |
Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells.
Topics: Base Sequence; Blotting, Western; Breast Neoplasms; Cell Division; Culture Media, Conditioned; DNA; Estradiol; Estrogen Antagonists; Fulvestrant; Humans; Insulin-Like Growth Factor I; Molecular Sequence Data; Polyunsaturated Alkamides; RNA, Messenger; Steroids; Tamoxifen; Tumor Cells, Cultured | 1995 |
Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Genetic Vectors; Humans; Polyunsaturated Alkamides; Receptors, Estrogen; RNA Splicing; RNA, Messenger; RNA, Neoplasm; Tamoxifen; Transfection; Tumor Cells, Cultured | 1997 |
Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor.
Topics: Bucladesine; Cell Line; Colforsin; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Osteoblasts; Polymerase Chain Reaction; Polyunsaturated Alkamides; Progesterone Congeners; Promegestone; Receptors, Estrogen; RNA, Messenger; Sensitivity and Specificity; Time Factors; Up-Regulation | 1998 |
Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Division; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Polyunsaturated Alkamides; Proto-Oncogene Proteins; S Phase; Tamoxifen; Tumor Cells, Cultured; Zinc Sulfate | 1997 |
Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability.
Topics: Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Fulvestrant; Humans; Ligands; Molecular Weight; Peptide Fragments; Polyunsaturated Alkamides; Protein Conformation; Receptors, Estrogen; Tamoxifen; Trypsin | 1999 |
Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family.
Topics: Blotting, Northern; Blotting, Western; Breast Neoplasms; DNA Primers; Drug Resistance, Neoplasm; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Polyunsaturated Alkamides; Receptor, ErbB-2; Reverse Transcriptase Polymerase Chain Reaction; Tamoxifen; Tumor Cells, Cultured | 1999 |
Resistance to different antiestrogens is caused by different multi-factorial changes and is associated with reduced expression of IGF receptor Ialpha.
Topics: Blotting, Western; Breast Neoplasms; Cell Fusion; Cell Line, Tumor; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Flow Cytometry; Fulvestrant; Humans; Insulin-Like Growth Factor Binding Protein 2; Microscopy, Phase-Contrast; Neoplasms, Hormone-Dependent; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-bcl-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 2003 |
Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Proteins; Oligonucleotide Array Sequence Analysis; Oligonucleotides, Antisense; Polyunsaturated Alkamides; Receptor, IGF Type 1; Tamoxifen | 2006 |
Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Breast Neoplasms; Casein Kinase II; Caspases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-bcl-2; Tamoxifen; Time Factors; Transfection | 2007 |